Gender Male
Prior to joining Illumina, Dave was the chief commercial officer of Foundation Medicine, a company dedicated to transforming cancer care by identifying molecular alterations in each patient’s unique cancer and matching them with potential targeted therapies and immunotherapies. There, he led all commercial functions globally, including sales,
marketing, client services, payer relations and medical affairs.
Before that, Dave lead the oncology business unit at Life Technologies, responsible for the establishment of a clinical oncology strategy, centered on a central lab services model providing support to both research and clinical customers. After Thermo Fisher acquired Life Technologies, he transitioned to Thermo’s anatomic pathology division, where he oversaw all commercial operations globally.
Previously, as the chief commercial officer at Clarient, Dave oversaw all commercial operations, including sales, marketing and client services. Over a five-year period, Clarient’s commercial team grew from start-up to $100M in revenue, culminating in the acquisition of the company by GE Healthcare in 2010.
